Abstract:The purpose of the present study was to explore the expression changes of intermedin/adrenomedullin 2 (IMD/ADM2), a novel small molecular bioactive peptide, and its receptors, calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMP1, RAMP2, RAMP3) in the right ventricle of rats with chronic hypoxia-induced pulmonary hypertension. Twenty male Sprague-Dawley rats were randomly divided into 4-week hypoxia group and normal control group (each n=10). The rats in hypoxia group were placed in an isobaric hypoxic chamber, in which O(2) content was maintained at 9%-11% by delivering N(2), and CO(2) content was maintained at <3% for 4 weeks (8 h/d, 6 d/week). The rats in the control group were housed in room air. The protein levels of IMD/ADM2 and adrenomedullin (ADM) in blood plasma and right ventricular tissue were measured by radioimmunoassay. The mRNA expressions of IMD/ADM2, ADM and their receptors CRLR, RAMP1, RAMP2, RAMP3 in right ventricular tissue were determined by reverse transcription-polymerase chain reaction (RT-PCR). The results showed that the ratio of right ventricle weight to left ventricle plus septum weight [RV/(LV+S)] and mean pulmonary arterial pressure (mPAP) were higher in hypoxia group than those in the control group (all P<0.01), suggesting that the rat model of pulmonary hypertension was successfully established. However, the mean carotid arterial pressure (mCAP) between the two groups had no significant difference. Compared with that in the control group, ADM contents in plasma and right ventricular tissue in hypoxia group increased by 1.26 and 1.68 folds (all P<0.01), respectively. Likewise, IMD/ADM2 contents in blood plasma and right ventricular tissue in hypoxia group increased by 0.90 and 1.19 folds (P<0.01), respectively, compared with that in the control group. The data of RT-PCR showed that mRNA levels of ADM, IMD/ADM2 and RAMP2 in hypoxia group increased by 155.1% (P<0.01), 80.9% (P<0.01) and 52.9% (P<0.05), respectively, compared with those in the control group. There were no significant differences in mRNA expressions of CRLR, RAMP1 and RAMP3 between the two groups (all P>0.05). Taken together, the results show that the level of IMD/ADM2 increases in the rats with chronic hypoxia-induced pulmonary hypertension.

The Content and Distribution of CGRP in Rats with Hypoxic Pulmonary Hypertention

Involvement of CapG in Proliferation and Apoptosis of Pulmonary Arterial Smooth Muscle Cells and in Hypoxia-Induced Pulmonary Hypertension Rat Model

Long Noncoding RNA Expression Profiles of Hypoxic Pulmonary Hypertension Rat Model.

Ghrelin Ameliorates Hypoxia-Induced Pulmonary Hypertension Via Phospho-Gsk3 Β/β-Catenin Signaling in Neonatal Rats.

Ghrelin Ameliorates Hypoxia-Induced Pulmonary Hypertension Via Phospho-Gsk3 Beta/Beta-Catenin Signaling In Neonatal Rats

CRH receptor type 1 mediates continual hypoxia-induced changes of immunoreactive prolactin and prolactin mRNA expression in rat pituitary.

Crf Receptor Type 1 Mediates Continual Hypoxia-Induced Crf Peptide And Crf Mrna Expression Increase In Hypothalamic Pvn Of Rats

Ralationship Between the Changes of Cellular Signal Transduction of NO-sGC-c GMP and Pulmonary Hypertension Induced by Chronic Hypoxic Hypercapnia

Expression and distribution of 5-HT1B receptors in lung tissue in rats with hypoxic pulmonary hypertension

Corticotropin-releasing hormone receptor 1 coexists with endothelin-1 and modulates its mRNA expression and release in rat paraventricular nucleus during hypoxia.

Corticotropin-releasing factor receptor subtype 1 and somatostatin modulating hypoxia-caused downregulated mRNA of pituitary growth hormone and upregulated mRNA of hepatic insulin-like growth factor-I of rats.

HMGB1 Upregulates RAGE to Trigger the Expression of Inflammatory Factors in the Lung Tissue in a Hypoxic Pulmonary Hypertension Rat Model

Regulation of hypoxia-induced release of corticotropin-releasing factor in the rat hypothalamus by norepinephrine.

The response of growth hormone and prolactin of rats to hypoxia

Orexin A and hypoglossal discharge in a rat model of chronic intermittent hypobaric hypoxia

[Changes of Intermedin/adrenomedullin 2 and Its Receptors in the Right Ventricle of Rats with Chronic Hypoxic Pulmonary Hypertension].

Inhibition of CXCR4 ameliorates hypoxia-induced pulmonary arterial hypertension in rats.

Regulation of Rat Intrapulmonary Arterial Tone by Arachidonic Acid and Prostaglandin E2 During Hypoxia

The Regulatory Effect of Hydrogen Sulfide on the Cytokines of Hypoxic Pulmonary Hypertensive Rats

Regulatory Effect of Endogenous Carbon Monoxide on Hypoxic Pulmonary Hypertension and Pulmonary Vascular Structure

RETRACTED: HMGB1 Upregulates RAGE to Trigger the Expression of Inflammatory Factors in the Lung Tissue in a Hypoxic Pulmonary Hypertension Rat Model (retracted Article)